Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Resectable”

237 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 237 results

Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT03314532
What this trial is testing

The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Surgical ResectionHCC
Second Affiliated Hospital, School of Medicine, Zhejiang University 230
Testing effectiveness (Phase 2)Looking for participantsNCT06420440
What this trial is testing

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

Who this might be right for
HCC
Chen Xiaoping 160
Large-scale testing (Phase 3)Study completedNCT00870558
What this trial is testing

Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer

Who this might be right for
Liver Cancer
Hospices Civils de Lyon 120
Early research (Phase 1)UnknownNCT03652467
What this trial is testing

The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Jinan Military General Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)Study completedNCT00617981
What this trial is testing

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Imunon 701
Not applicableStudy completedNCT03138031
What this trial is testing

Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
The National Ribat University 23
Testing effectiveness (Phase 2)WithdrawnNCT01194206
What this trial is testing

Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
Case Comprehensive Cancer Center
Not applicableUnknownNCT05530785
What this trial is testing

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Yongchang Zhang 35
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06512467
What this trial is testing

Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableLooking for participantsNCT05717738
What this trial is testing

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Tongji Hospital 300
Early research (Phase 1)Study completedNCT01031784
What this trial is testing

Radioactive Holmium Microspheres for the Treatment of Liver Metastases

Who this might be right for
Liver MetastasisLiver Tumors
UMC Utrecht 15
Testing effectiveness (Phase 2)Study completedNCT05908786
What this trial is testing

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 62
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Large-scale testing (Phase 3)Not Yet RecruitingNCT07475026
What this trial is testing

Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 198
Post-approval studies (Phase 4)UnknownNCT02138981
What this trial is testing

Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Sun Yat-sen University 436
Testing effectiveness (Phase 2)UnknownNCT01182272
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

Who this might be right for
Liver Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 36
Load More Results